BioSpace News Archive

Business

Pharnext Reports First Half 2022 Financial Results

Pharnext SA, an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, announces its financial results for the first half of 2022.

October 17, 2022
·
8 min read
Business

2022-23 AAOMS officers and trustees announced

Paul J. Schwartz, DMD, was introduced as the 2022-23 President of the American Association of Oral and Maxillofacial Surgeons during its recent Annual Meeting in New Orleans, La.

October 17, 2022
·
4 min read
Business

AAOMS recognizes award winners during 104th Annual Meeting

The American Association of Oral and Maxillofacial Surgeons honored nearly 40 award recipients for their accomplishments in education, research, advocacy and humanitarianism at the association’s 104th Annual Meeting, Scientific Sessions and Exhibition.

October 17, 2022
·
3 min read
Genetown

Galecto to Host Virtual Investor Event and Webcast to Review Topline Data from GULLIVER-2 Trial on Tuesday, November 8, 2022

Galecto, Inc. announced that it will host a live conference call and webcast at 8:00 am ET on Tuesday, November 8, 2022 to review topline data from the Company’s Phase 1b/2a GULLIVER-2 trial for liver cirrhosis.

October 17, 2022
·
2 min read
Drug Development

Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia

Milestone Pharmaceuticals Inc. announced positive topline efficacy and safety data from the Phase 3 RAPID clinical trial of etripamil, the Company’s investigational calcium channel blocker, in patients with paroxysmal supraventricular tachycardia.

October 17, 2022
·
9 min read
Pharm Country

New, peer reviewed study shows novel DermiSphere™ hydrogel enhances skin grafts

FesariusTherapeutics, Inc., an emerging bioregenerative technology company, announced the first publication describing its proprietary DermiSphere™ differential density collagen platform technology for advanced dermal regeneration.

October 17, 2022
·
2 min read
Genetown

Moderna Announces Update to 2022 Supply Agreement with Gavi that Secures Access to Updated Variant-Specific COVID-19 Vaccines for Low-and-Middle Income Countries

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Gavi, the Vaccine Alliance, have mutually agreed to cancel remaining pending orders under the current COVID-19 vaccine supply agreement for 2022.

October 17, 2022
·
4 min read
Genetown

Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109, Drug Candidate with the Potential to be the First Oral Therapy for Obstructive Sleep Apnea (OSA)

Apnimed announced positive topline results from the MARIPOSA Phase 2b trial, an efficacy, safety and dose-finding study of one-month duration.

October 17, 2022
·
7 min read
Business

KalVista Pharmaceuticals Announces Appointment of Brian J.G. Pereira, M.D. as Board Chairman

KalVista Pharmaceuticals, Inc. announced that the Board of Directors has appointed current member Brian J.G. Pereira, M.D., as Chairman, effective immediately.

October 17, 2022
·
4 min read
Business

Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts

Replay today announced that it has established a scientific advisory board (SAB) comprising ten experts across a broad range of areas of scientific importance in genomic medicine and cell therapy.

October 17, 2022
·
6 min read